Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-07-28, Stock:PFE, The news for the past five days is as follows:
2020-07-21: NEWS1: Why Top-Notch Coronavirus Stock BioNTech Surged For A Third Day.NEWS2: Lawmaker Presses Drugmakers on Covid-19 Vaccine Pricing.NEWS3: Coronavirus latest: Tuesday, July 21.NEWS4: Why BioNTech Stock Jumped Today.NEWS5: House panel holds hearing with COVID-19 vaccine makers.NEWS6: Dow Jones Up 300 Points As Oil Stocks Surge; More Coronavirus Stimulus Ahead?.NEWS7: Pfizer (PFE) Expected to Beat Earnings Estimates: Should You Buy?.NEWS8: Vaccine Makers Tell Congress They Are Hopeful, but Challenges Remain.NEWS9: BioNTech plans share sale with Pfizer logging large order.NEWS10: 3 Small Biotechs in Focus on Promising Coronavirus Vaccine Data.NEWS11: Analysts Are Starting to Pick Their Covid-19 Vaccine Winners, but There’s Still a Long Way to Go.NEWS12: Coronavirus vaccine developers vow diversity in clinical trials.NEWS13: Have $2,000? Consider Buying These 2 Top Coronavirus Stocks.NEWS14: BioNTech to offer 5 million ADS and follow with rights offering.NEWS15: Can Pfizer (PFE) Deliver a Beat in Coronavirus-Hit Q2 Earnings?.NEWS16: Gold Up Over Prospective U.S. and EU Stimulus Measures.NEWS17: U.K. Secures 30 Million Doses of Coronavirus Vaccine Candidate From Pfizer and BioNTech.
2020-07-22: NEWS1: Asian Stocks Down Over Mounting U.S.-China Tensions.NEWS2: US Indexes Close Higher Wednesday.NEWS3: Brazil Reports Record Cases; Texas Deaths Hit High: Virus Update.NEWS4: Brazil eyes buying Pfizer vaccine to be tested in country.NEWS5: Biotech ETFs to Gain on Coronavirus Vaccine Progress.NEWS6: Stock Market Today: Dow Edges Higher Despite Growing Rift With China.NEWS7: US STOCKS-Wall Street ends choppy session higher on mixed earnings, U.S. stimulus debate.NEWS8: Pfizer, BioNTech Score $2 Billion Deal For U.S. Coronavirus Vaccine.NEWS9: Trump: COVID-19 will get worse before it gets better.NEWS10: Coronavirus latest: Wednesday, July 22.NEWS11: Pfizer, McDonald's share gains contribute to Dow's 125-point jump.NEWS12: Stock Market Today With Jim Cramer: Don't Buy Pfizer Now.NEWS13: Why BioNTech Stock Jumped Today.NEWS14: US STOCKS-Wall Street see-saws as investors weigh mixed earnings, stimulus prospects.NEWS15: U.S. to pay Pfizer, BioNTech $1.95B for 100M doses of COVID-19 vaccine.NEWS16: Pfizer Vaccine Deal at $20 a Dose Sets Ceiling for Rivals.NEWS17: Fmr. Obama Economic Adviser reveals top 3 economic priorities .NEWS18: Pfizer’s Covid Vaccine Contract Spurs ‘Extreme’ Drugmaker Gains.NEWS19: Dow Jones Rises 100 Points Amid U.S.-China Tension, As Pfizer Soars On Coronavirus Vaccine Deal; Microsoft, Tesla Earnings Due Late.NEWS20: US STOCKS-S&P 500, Dow rise as fiscal stimulus hopes offset Sino-U.S. worries.NEWS21: A $2 Billion Bet on Pfizer’s Covid Vaccine Is Worth It.NEWS22: U.S. coronavirus infections, hospitalizations rise, crisis could worsen.NEWS23: Stocks on the move: Pfizer shares rise on U.S. vaccine deal, Slack files complaint with EU against Microsoft.NEWS24: Dow up 50 points on gains in shares of Pfizer, McDonald's.NEWS25: Dow Rises on Pfizer Vaccine Deal, Wall Street Eyes U.S.-China Tensions.NEWS26: Dow Jones Rises Amid U.S.-China Tension, As Pfizer Soars On Coronavirus Vaccine Deal; Microsoft, Tesla Earnings Due Late.NEWS27: US STOCKS-Wall St inches higher as tech boost offsets Sino-U.S. worries.NEWS28: McDonald's, Pfizer share gains contribute to Dow's 336-point rally.NEWS29: U.S. pays Pfizer, BioNTech $2 bln for vaccines.NEWS30: Pfizer and BioNTech Ink Deal with U.S. Government for Big Coronavirus Vaccine Purchase.NEWS31: The Zacks Analyst Blog Highlights: AstraZeneca, Pfizer, Moderna, Vaxart and Novovax.NEWS32: Dow Jones Today, Stocks Turn Higher: Tesla, Microsoft Rise Ahead Of Earnings; Pfizer Spikes On HHS Vaccine Deal.NEWS33: Dow climbs nearly 75 points on gains in Pfizer, McDonald's shares.NEWS34: Pfizer, McDonald's share gains contribute to Dow's nearly 75-point jump.NEWS35: U.S. government orders 300M coronavirus vaccine doses from Pfizer.NEWS36: Pfizer Will Charge the U.S. $19.50 a Dose for Its Covid-19 Vaccine. The Stock Jumps..NEWS37: Dow Dips on Rising U.S.-China Tensions, Pfizer Moves Higher.NEWS38: Pfizer Shares Leap After Agreeing To Provide US With 600 Million COVID-19 Vaccine Doses.NEWS39: Is Now a Good Time to Buy Pfizer Stock?.NEWS40: US STOCKS-S&P 500, Dow set for tepid open as Sino-U.S. ties worsen.NEWS41: Pfizer, BioNTech Surge On US Gov Deal For 600M Covid-19 Vaccine Doses.NEWS42: Pfizer Stock Is Jumping, Best Buy Soars, and the Dow Edges Down.NEWS43: BioNTech, Pfizer shares gain on U.S. funding for coronavirus vaccine doses.NEWS44: U.S. has contract with Pfizer for 100 mln coronavirus vaccine doses -Azar.NEWS45: U.S. to pay Pfizer, BioNTech $1.95 billion for millions of COVID-19 vaccine doses.NEWS46: U.S. government engages Pfizer to produce millions of doses of COVID-19 vaccine.NEWS47: Pfizer and BioNTech Announce an Agreement with U.S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2.NEWS48: Stocks - Best Buy, Pfizer Climb Premarket; Snap Drops.
2020-07-23: NEWS1: Surgeon General: US has a racial 'health disadvantage' — even without coronavirus.NEWS2: Stock market news live updates: Stocks fall after jobless claims come in worse than expected.NEWS3: Why BioNTech Stock Sank Today.NEWS4: Pfizer Analyst Says COVID-19-Driven Rally Not Backed By Vaccine Economics.NEWS5: Coronavirus: Why your local hospital may also need stimulus checks.NEWS6: Will Pfizer's (PFE) BioPharma Unit Drive Its Q2 Earnings?.NEWS7: The Zacks Analyst Blog Highlights: AstraZeneca, BioNTech, Pfizer, Cimarex Energy, Diamondback Energy, Centennial Resource Development and Bonanza Creek Energy.NEWS8: Moderna’s Vaccine Will Likely Be Approved, Analyst Says. Why the Stock Is ‘Unattractive.’.NEWS9: Dow Jones Today, Stocks Mixed After Jobs Data; Tesla's Unexpected Profit, Twitter's 186-Million Surprise.NEWS10: Pfizer (PFE) Looks Good: Stock Adds 5.1% in Session.NEWS11: U.S. sets global benchmark for COVID-19 vaccine price at around the cost of a flu shot.NEWS12: PRESS DIGEST- Wall Street Journal - July 23.NEWS13: Pfizer in Pact With U.S. for 100 Million Covid-19 Vaccine Doses.NEWS14: The Dow’s Rally Above 27,000 Was About More Than Pfizer’s Vaccine.
2020-07-24: NEWS1: Trump Signs 4 Executive Orders Aimed at Lowering Drug Prices. What to Know..NEWS2: Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers.NEWS3: Trump signs executive order aimed at lowering drug prices.NEWS4: Stock Market Rally Reverses On Big Tech, China Tensions; Tesla, Intel, AMD, Microsoft, Chipotle Earnings In Focus.NEWS5: Intel, Cisco share losses contribute to Dow's 225-point drop.NEWS6: Novavax’s 3,500% Surge on a Covid-19 Vaccine Faces First Test.NEWS7: Intel, Pfizer share losses contribute to Dow's 150-point drop.NEWS8: 5 High-Yield Drug Stocks That Are Undervalued With Great Upside.NEWS9: Dow falls 219 points on losses in Intel, Pfizer stocks.NEWS10: Vaccine checkup: Where pharmaceutical companies stand in the fight against COVID-19.NEWS11: Dow falls 150 points on losses in Intel, Pfizer shares.NEWS12: Dow's 75-point fall led by losses in Intel, Pfizer stocks.NEWS13: Pharma Stock Roundup: NVS, RHHBY Earnings, AZN, PFE Coronavirus Vaccine Early Data.NEWS14: Understanding Pfizer's Unusual Options Activity.NEWS15: Intel, Apple Inc. share losses lead Dow's 162-point drop.NEWS16: The Further It Lags in the Vaccine Race, the Riskier Inovio Stock Looks.NEWS17: Chinese COVID-19 vaccine candidate shows promise in animal tests.
2020-07-27: NEWS1: WRAPUP 1-Moderna, Pfizer start decisive COVID-19 vaccine trials, eye year-end launches.NEWS2: Pfizer-BioNTech begin global study of lead COVID-19 vaccine candidate.NEWS3: Pfizer, BioNTech's COVID vaccine candidate enters late-stage trial.NEWS4: 3 Things To Look For In Pfizer's Q2 Earnings Report.NEWS5: Moderna Starts Phase 3 Trial For Its Coronavirus Vaccine; MRNA Stock Jumps.NEWS6: Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study.NEWS7: AstraZeneca Inks Multibillion-Dollar Cancer Treatment Collaboration.NEWS8: As bleak COVID-19 headlines mount, investors worry only about the facts ‘they can live with,’ analyst says.NEWS9: Here's How Much Investing $1,000 In Pfizer Stock Back In 2010 Would Be Worth Today.NEWS10: Why traders with an appetite for risk are like ‘the neighbor of a serial killer’.NEWS11: Top Research Reports for Facebook, Verizon & Pfizer.NEWS12: U.S. drugmaker earnings heat up this week with spotlight on vaccine news.NEWS13: AstraZeneca Inks Multibillion-Dollar Cancer Treatment Collaboration.NEWS14: What Lies Ahead for Healthcare ETFs in Q2 Earnings?.NEWS15: Exclusive: EU talks with Pfizer, Sanofi, J&J on COVID vaccines hit snags - sources.NEWS16: Unusual Options Activity Insight: Pfizer.NEWS17: Global Markets Review: Euro Rises After EU Deal.NEWS18: Pfizer Surges On Coronavirus Vaccine Supply Deals — But Is PFE Stock A Buy?.NEWS19: Pfizer Reports Earnings Tomorrow. Here’s What to Expect..NEWS20: Why Earnings Season Could Be Great for Pfizer (PFE).NEWS21: US STOCKS-Stimulus, dovish Fed bets set to lift Wall St ahead of earnings rush.NEWS22: US STOCKS-Futures firm with focus on Fed, earnings rush.NEWS23: RPT-BUZZ-U.S. stocks weekly: Tug of war.

Answer: Rise